CMA identified a 3.801 Mb heterozygous deletion on Xp21.1p11.4 affecting 17 genes, including CYBB and OTC. Variants in CYBB are associated with X-linked chronic granulomatous disease (CGD) and immunodeficiency 34. Here, OTC is linked to immunodeficiency disease.